This week the EU Commission announced (click here) another time-bound extension of its regulatory equivalence recognition under Article 25 of EMIR for UK central counterparties (CCPs) effective from 1 July 2025.
What is it about?
Neutral observers might question why temporary equivalence seems only to apply to UK CCPs when it is usually granted on an indefinite basis (a current list of equivalent Third Country CCPs may be found here). EU authorities maintain the narrative that reducing the EU’s over-reliance on systemically important UK CCPs will reduce risks impacting the EU’s financial stability. EMIR 3 compels EU firms to move a portion of their clearing to EU CCPs to this end for certain contracts.
The Bank of England duly acknowledged the EU Commission’s decision to extend its equivalence recognition here.
Article 25 equivalence under EU EMIR should not be conflated with Article 2a equivalence which remains elusive for UK markets. Without Article 2a equivalence, which the EU has thus far declined to recognise, Exchange Traded Derivatives (ETDs) traded on non-equivalent third country venues are treated as OTC Derivatives under EU EMIR for clearing threshold calculation purposes.